Clinical Trial Update: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two rituximab regimens for maintaining or achieving remission in ANCA-associated vasculitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Granulomatosis With Polyangiitis, Microscopic Polyangiitis | Phase 3 | Status: COMPLETED